Listed by the USPTO as WHALEY, PABLO S
Tech Center 3600 • Art Units: 1631 1684 3619
This examiner grants 25% of resolved cases
WHALEY, PABLO S is assigned to Tech Center 3600 and Art Unit 1631. His record covers 543 resolved cases, with an allowance rate of 25.0% and a median of 1903 days to allowance. The 21.3% interview lift is positive, but it does not eliminate the difficulty reflected in the low allowance rate. Interviews may therefore be most useful when supported by a specific claim and prior art theory.
The listed companies are Hill's Pet Nutrition Inc., Myriad Genetics Inc., and Thermo Fisher Scientific. The listed firms are FOLEY & LARDNER LLP, Nixon Peabody LLP, and BALLARD SPAHR LLP. The 1903-day median signals extended prosecution timing. Practitioners should identify fallback positions early, preserve technical support for amendments, and use interviews to determine whether a focused amendment can address the examiner's central objections.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17616494 | Likelihood Ratios for Out-of-Distribution Detection | Final Rejection | Google LLC |
| 17786617 | Transdermal Sedative Release Control in Autonomous Imaging | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 19390421 | COMPUTING ARCHITECTURE FOR COMPONENT-LEVEL PROGRESSION ASSESSMENT IN COMPOSITE ENTITIES | Final Rejection | Generation Lab, Inc. |
| 17753871 | Methods of Treatments Based Upon Molecular Characterization of Breast Cancer | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17791970 | ATAC-SEQ DATA NORMALIZATION AND METHOD FOR UTILIZING SAME | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17416938 | A METHOD AND DEVICE FOR PREDICTING EVOLUTION OVER TIME OF A VISION-RELATED PARAMETER | Non-Final OA | ESSILOR INTERNATIONAL |
| 18508755 | STRATIFICATION METHOD THAT DETERMINES THE PROGNOSIS OF BREAST CANCER AT A PERSONALIZED LEVEL | Non-Final OA | The Research Foundation for The State University of New York |
| 19088442 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | Non-Final OA | Myriad Genetics, Inc. |
| 18646644 | ELECTRONIC VARIANT CLASSIFICATION | Final Rejection | Myriad Genetics, Inc. |
| 17499284 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | Non-Final OA | Myriad Genetics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy25.0% of resolved applications examined by Pablo S Whaley were allowed (543 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +21.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Pablo S Whaley took 1,903 days on average from filing to allowance.
Pablo S Whaley examines applications in Art Unit 1631 in Tech Center 3600 (Transportation, E-Commerce & Mechanical Systems).
